supp.fit

Vitamin E, Vitamin C and Vitamin B6: study protocols

9 study groups took Vitamin E together with Vitamin C and Vitamin B6. These are the doses the studies gave. They are not a recommendation.

Vitamin E: what the research found →

Dose per serving from research: Vitamin E

8 study groups in 6 studies say how much Vitamin E participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 25 mg to 50 mg, 38% of 8 study groups.

Daily doseStudy groups
5 mg or less
1
5 mg to 10 mg
2
10 mg to 25 mg
1
25 mg to 50 mg
3
50 mg to 100 mg
1

Dose per serving from research: Vitamin C

9 study groups in 7 studies say how much Vitamin C participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 50 mg to 100 mg, 44% of 9 study groups.

Daily doseStudy groups
25 mg to 50 mg
2
50 mg to 100 mg
4
100 mg to 250 mg
1
250 mg to 500 mg
2

Dose per serving from research: Vitamin B6

9 study groups in 7 studies say how much Vitamin B6 participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 1 mg to 2.5 mg, 44% of 9 study groups.

Daily doseStudy groups
500 mcg or less
1
500 mcg to 1 mg
2
1 mg to 2.5 mg
4
2.5 mg to 5 mg
1
5 mg to 10 mg
0
10 mg to 25 mg
0
25 mg to 50 mg
1

Commonly used together

9 of 9 study groups took Vitamin E, Vitamin C and Vitamin B6 with something else. Shown: what 3 or more different studies gave. The 10 most common of 11.

What was given together, not what works together.

Taken withStudy groups
Vitamin B12
9
Folic Acid
8
Zinc
6
Selenium
5
Vitamin D
5
Copper
4
Iron
4
Vitamin A
4
Iodine
3
Niacin
3

9 study groups

Study
Effects of multimicronutrient supplementation on helminth reinfection: a randomized, controlled trial in Kenyan schoolchildren
2003 · multimicronutrient supplementation · Schoolchildren in Nyanza Province, Kenya; age and sex not specified
8 mg50 mg1.7 mg335 days—
Effects of maternal micronutrient supplementation on fetal loss and infant mortality: a cluster-randomized trial in Nepal
2003 · Multiple micronutrients · Pregnant women in rural Nepal
10 mg100 mg2.2 mg——
Effects of Souvenaid on plasma micronutrient levels and fatty acid profiles in mild and mild-to-moderate Alzheimer's disease
2015 · Active group (RCT1, RCT2 and RCT3) · Men and women aged 50 years or older with mild or mild-to-moderate Alzheimer's disease; RCT3 participants were on stable approved Alzheimer's medication, while RCT1 and RCT2 participants were drug-free for Alzheimer's medication.
40 mg80 mg1 mg24 weeks501
Effects of Souvenaid on plasma micronutrient levels and fatty acid profiles in mild and mild-to-moderate Alzheimer's disease
2015 · Active product during open-label extension (OLE) · Men and women aged 50 years or older with mild Alzheimer's disease who completed RCT2.
40 mg80 mg1 mg24 weeks201
Newborn micronutrient status biomarkers in a cluster-randomized trial of antenatal multiple micronutrient compared with iron folic acid supplementation in rural Bangladesh
2020 · MM · Pregnant women in rural Bangladesh; age range not specified; no disease condition specified
15 mg85 mg1.9 mg—176
Multiple Micronutrient Powder Reduces Vitamin E Deficiency in Brazilian Children: A Pragmatic, Controlled Clinical Trial
2019 · intervention group · Children aged 6–9 months at the start of the study, male or female, attending primary health care centers in Goiânia, Brazil
5 mg30 mg500 mcg90 days107
Antioxidant supplementation with or without B-group vitamins after acute ischemic stroke: a randomized controlled trial
2006 · Antioxidant vitamins plus B-group vitamins · Acute ischemic stroke patients treated within 12 hours of symptom onset
800 IU500 mg50 mg2 weeks24
Use of Nutraceuticals in Elderly to Fight Inflammation and Immuno-Senescence: A Randomized Case-Control Study
2022 · TG1 · Hospitalized adults older than 65 years; sex not restricted; recruited for causes other than cancer, with specified immune-disease and infection exclusions
45 mg135 mg2.1 mg12 weeks30
Use of Nutraceuticals in Elderly to Fight Inflammation and Immuno-Senescence: A Randomized Case-Control Study
2022 · TG2 · Hospitalized adults older than 65 years; sex not restricted; recruited for causes other than cancer, with specified immune-disease and infection exclusions
90 mg270 mg4.2 mg6 weeks30